Richard Vincent

Insider profile

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Financial Officer, Secretary, Director Sorrento Therapeutics Inc Sept. 1, 2012 - Jan. 30, 2015
Part-time Chief Financial Officer Sorrento Therapeutics Inc Feb. 5, 2010 - Sept. 1, 2012

Richard Vincent's trades of Oncternal Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
294.08
Quantity 1,533 -29.6%
Value US$1,562,505
Transaction date
Purchase
Price
173.37
Quantity 26,689 -46.7%
Value US$86,772
Transaction date
Purchase
Price
1.45
Quantity 356 +0.4%
Value US$516
Transaction date
Purchase
Price
1.65
Quantity 2,500 +3.1%
Value US$4,125
Transaction date
Purchase
Price
1.70
Quantity 5,000 +6.6%
Value US$8,500
Transaction date
Purchase
Price
1.80
Quantity 5,000 +7.1%
Value US$9,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-04-14 2023-04-13 B Purchase
98,725 -16.8%
241.76
US$3,108,385
98,725 -16.8% 241.76 US$3,108,385
2022-03-28 2022-03-28 B Purchase
1,533 -29.6%
294.08
US$1,562,505
1,533 -29.6% 294.08 US$1,562,505
2022-03-28 2022-03-25 B Purchase
26,689 -46.7%
173.37
US$86,772
26,689 -46.7% 173.37 US$86,772
2022-03-28 2022-03-25 B Purchase
5 +0.0%
1.48
US$7
5 +0.0% 1.48 US$7
2022-03-28 2022-03-25 B Purchase
356 +0.4%
1.45
US$516
356 +0.4% 1.45 US$516
2022-03-28 2022-03-24 B Purchase
3 +0.0%
1.45
US$4
3 +0.0% 1.45 US$4
2022-01-31 2022-01-28 B Purchase
2,500 +3.1%
1.65
US$4,125
2,500 +3.1% 1.65 US$4,125
2022-01-31 2022-01-27 B Purchase
5,000 +6.6%
1.70
US$8,500
5,000 +6.6% 1.70 US$8,500
2022-01-31 2022-01-27 B Purchase
5,000 +7.1%
1.80
US$9,000
5,000 +7.1% 1.80 US$9,000